LH · 10-Q · 2026Q3 · Full report
Acquisition / Partnership / Divestiture
LABCORP HOLDINGS INC. · 2026-10-30 · Importance 65 · Surprise 60 · In source text
On June 28, 2026, Labcorp agreed to acquire select assets of an outreach laboratory services business for approximately $155.0 million, subject to customary closing conditions and approvals. On October 15, it announced an agreement to acquire select BioReference Health laboratory assets for up to $872.0 million, including $722.0 million cash at closing and up to $150.0 contingent on 4Kscore Test revenue; closing was anticipated in mid-2027. The BioReference assets include clinical and women’s health testing, urology, corrections, patient service centers, and the FDA-approved 4Kscore Test. Labcorp also agreed to acquire Myriad Genetics’ Prenatal Health testing business for approximately $210.0 million in cash plus inventory, and Millennium Health for up to $375.0 million, including $245.0 million cash at closing and up to $130.0 million contingent consideration.
Key facts
- On October 15, 2026, Labcorp agreed to acquire select BioReference Health laboratory business assets from OPKO Health for up to $872.0 million, including $722.0 million cash at closing and up to $150.0 contingent on 4Kscore Test revenue; the transaction is anticipated to close mid-2027, subject to approvals and customary conditions. source
- On October 20, 2026, Labcorp agreed to acquire Myriad Genetics’ Prenatal Health testing business for approximately $210.0 million in cash plus the value of inventory at closing; closing is expected in early 2027, subject to customary conditions and regulatory approvals. source
- On October 23, 2026, Labcorp agreed to acquire Millennium Health for up to $375.0 million, including $245.0 million cash at closing and up to $130.0 million contingent on specified future events; the transaction is anticipated to close in 2026, subject to approvals and customary conditions. source
- Labcorp entered into an agreement on June 28, 2026, to acquire select assets of an outreach laboratory services business for approximately $155.0 million, subject to customary closing conditions and regulatory approvals. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | probable | -2.1% | On October 15, 2026, Labcorp agreed to acquire select BioReference Health laboratory business assets from OPKO Health for up to $872.0… |
| cash | negative | probable | -0.8% | On October 23, 2026, Labcorp agreed to acquire Millennium Health for up to $375.0 million, including $245.0 million cash at closing and up… |
| cash | negative | probable | -0.6% | On October 20, 2026, Labcorp agreed to acquire Myriad Genetics’ Prenatal Health testing business for approximately $210.0 million in cash… |
| cash | negative | probable | -0.4% | Labcorp entered into an agreement on June 28, 2026, to acquire select assets of an outreach laboratory services business for approximately… |